Laura Campbell
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Laura Campbell has a total of 90 co-authors. Here are the top co-authors by number of shared publications:
- Matthew J. Hardman
Centre for Biomedicine, Hull York Medical School, University of Hull, Hull, HU6 7RX, UK
16 shared publications - Elaine Emmerson
The University of Edinburgh
8 shared publications Gillian S. Ashcroft
The Healing Foundation Centre, Faculty of Life Sciences, The University of Manchester, Manchester, UK
6 shared publicationsHelen Williams
Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK
4 shared publicationsPierre Chambon
Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, Collège de France, Paris, France
4 shared publications- Sheena Margaret Cruickshank
Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, UK
4 shared publications
Latest Publications
- Open Access
Caecal epithelium-derived thymic stromal lymphopoietin is not required for protective immunity against whipworm
Recent research examining classical type two alarmin TSLP has uncovered non-epithelial cellular sources of the cytokine during various murine challenges. Trichuris muris is a key model of type two immunity in the intestine with expulsion being TSLP-dependent. Previous research was suggestive of epithelial production of TSLP in the caecum, but it’s production during infection has not been characterised in detail. Here, using qPCR, transcript-based imaging, and conditional knockout, we demonstrate caecal epithelium to be a poor source of Tslp , and that non-epithelial upregulation occurs during Trichuris infection, peaking around day 14 post-infection. Conditional knockout of TSLP expression in caecal epithelial cells did not here impact parasite expulsion, but, surprisingly, neutralisation of TSLP from days 15 to 25 produced full susceptibility. These data build on previous work to raise important questions regarding the interaction of TSLP with immunity broadly, as well as the conditions for production of immunity to intestinal helminths.
Open AccessCaecal epithelium-derived thymic stromal lymphopoietin is not required for protective immunity against whipworm
Recent research examining classical type two alarmin TSLP has uncovered non-epithelial cellular sources of the cytokine during various murine challenges. Trichuris muris is a key model of type two immunity in the intestine with expulsion being TSLP-dependent. Previous research was suggestive of epithelial production of TSLP in the caecum, but it’s production during infection has not been characterised in detail. Here, using qPCR, transcript-based imaging, and conditional knockout, we demonstrate caecal epithelium to be a poor source of Tslp , and that non-epithelial upregulation occurs during Trichuris infection, peaking around day 14 post-infection. Conditional knockout of TSLP expression in caecal epithelial cells did not here impact parasite expulsion, but, surprisingly, neutralisation of TSLP from days 15 to 25 produced full susceptibility. These data build on previous work to raise important questions regarding the interaction of TSLP with immunity broadly, as well as the conditions for production of immunity to intestinal helminths.
- 1 April 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (4) , 1206-1216.e8
An Epidermal-Specific Role for Arginase1 during Cutaneous Wound Repair
- 1 April 2022
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 142 (4) , 1206-1216.e8
An Epidermal-Specific Role for Arginase1 during Cutaneous Wound Repair
- Open Access
- 3 October 2019
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 216 (12) , 2714-2723
ILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites
Host immunity to parasitic nematodes requires the generation of a robust type 2 cytokine response, characterized by the production of interleukin 13 (IL-13), which drives expulsion. Here, we show that infection with helminths in the intestine also induces an ILC2-driven, IL-13–dependent goblet cell hyperplasia and increased production of mucins (Muc5b and Muc5ac) at distal sites, including the lungs and other mucosal barrier sites. Critically, we show that type 2 priming of lung tissue through increased mucin production inhibits the progression of a subsequent lung migratory helminth infection and limits its transit through the airways. These data show that infection by gastrointestinal-dwelling helminths induces a systemic innate mucin response that primes peripheral barrier sites for protection against subsequent secondary helminth infections. These data suggest that innate-driven priming of mucus barriers may have evolved to protect from subsequent infections with multiple helminth species, which occur naturally in endemic areas.
- 3 October 2019
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 216 (12) , 2714-2723
Open AccessILC2s mediate systemic innate protection by priming mucus production at distal mucosal sites
Host immunity to parasitic nematodes requires the generation of a robust type 2 cytokine response, characterized by the production of interleukin 13 (IL-13), which drives expulsion. Here, we show that infection with helminths in the intestine also induces an ILC2-driven, IL-13–dependent goblet cell hyperplasia and increased production of mucins (Muc5b and Muc5ac) at distal sites, including the lungs and other mucosal barrier sites. Critically, we show that type 2 priming of lung tissue through increased mucin production inhibits the progression of a subsequent lung migratory helminth infection and limits its transit through the airways. These data show that infection by gastrointestinal-dwelling helminths induces a systemic innate mucin response that primes peripheral barrier sites for protection against subsequent secondary helminth infections. These data suggest that innate-driven priming of mucus barriers may have evolved to protect from subsequent infections with multiple helminth species, which occur naturally in endemic areas.
- 1 April 2019
- Published by Springer Nature in Nature Immunology
- Vol. 20 (5) , 571-580
The lung environment controls alveolar macrophage metabolism and responsiveness in type 2 inflammation
Fine control of macrophage activation is needed to prevent inflammatory disease, particularly at barrier sites such as the lungs. However, the dominant mechanisms that regulate the activation of pulmonary macrophages during inflammation are poorly understood. We found that alveolar macrophages (AlvMs) were much less able to respond to the canonical type 2 cytokine IL-4, which underpins allergic disease and parasitic worm infections, than macrophages from lung tissue or the peritoneal cavity. We found that the hyporesponsiveness of AlvMs to IL-4 depended upon the lung environment but was independent of the host microbiota or the lung extracellular matrix components surfactant protein D (SP-D) and mucin 5b (Muc5b). AlvMs showed severely dysregulated metabolism relative to that of cavity macrophages. After removal from the lungs, AlvMs regained responsiveness to IL-4 in a glycolysis-dependent manner. Thus, impaired glycolysis in the pulmonary niche regulates AlvM responsiveness during type 2 inflammation.
- 1 April 2019
- Published by Springer Nature in Nature Immunology
- Vol. 20 (5) , 571-580
The lung environment controls alveolar macrophage metabolism and responsiveness in type 2 inflammation
Fine control of macrophage activation is needed to prevent inflammatory disease, particularly at barrier sites such as the lungs. However, the dominant mechanisms that regulate the activation of pulmonary macrophages during inflammation are poorly understood. We found that alveolar macrophages (AlvMs) were much less able to respond to the canonical type 2 cytokine IL-4, which underpins allergic disease and parasitic worm infections, than macrophages from lung tissue or the peritoneal cavity. We found that the hyporesponsiveness of AlvMs to IL-4 depended upon the lung environment but was independent of the host microbiota or the lung extracellular matrix components surfactant protein D (SP-D) and mucin 5b (Muc5b). AlvMs showed severely dysregulated metabolism relative to that of cavity macrophages. After removal from the lungs, AlvMs regained responsiveness to IL-4 in a glycolysis-dependent manner. Thus, impaired glycolysis in the pulmonary niche regulates AlvM responsiveness during type 2 inflammation.
- Open Access
- 1 January 2019
- Published by Elsevier in Mucosal Immunology
- Vol. 12 (1) , 51-63
T-bet controls intestinal mucosa immune responses via repression of type 2 innate lymphoid cell function
- 1 January 2019
- Published by Elsevier in Mucosal Immunology
- Vol. 12 (1) , 51-63
Open AccessT-bet controls intestinal mucosa immune responses via repression of type 2 innate lymphoid cell function
- Open Access
- 1 November 2017
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 137 (11) , 2427-2436
Cutaneous Nod2 Expression Regulates the Skin Microbiome and Wound Healing in a Murine Model
- 1 November 2017
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 137 (11) , 2427-2436
Open AccessCutaneous Nod2 Expression Regulates the Skin Microbiome and Wound Healing in a Murine Model
- 10 November 2016
- Published by American Diabetes Association in Diabetes Care
- Vol. 39 (12) , e222-e223
Response to Comment on Crews et al. Role and Determinants of Adherence to Off-loading in Diabetic Foot Ulcer Healing: A Prospective Investigation. Diabetes Care 2016;39:1371–1377
We were pleased that van Netten et al. (1) appreciate the importance of our article (2) substantiating the relationship between adherence to off-loading modalities and healing of diabetic foot ulcers (DFUs). Their letter contained several comments regarding our article that we address here. The first comment by van Netten et al. is regarding the rationale for using a surrogate clinical outcome (ulcer area reduction) rather than ulcer healing by a fixed time, preferably 12 weeks, which would allow for direct comparisons with other articles on off-loading. It is important to note, as was outlined in our article, that the study associated with our publication was not limited …
- 10 November 2016
- Published by American Diabetes Association in Diabetes Care
- Vol. 39 (12) , e222-e223
Response to Comment on Crews et al. Role and Determinants of Adherence to Off-loading in Diabetic Foot Ulcer Healing: A Prospective Investigation. Diabetes Care 2016;39:1371–1377
We were pleased that van Netten et al. (1) appreciate the importance of our article (2) substantiating the relationship between adherence to off-loading modalities and healing of diabetic foot ulcers (DFUs). Their letter contained several comments regarding our article that we address here. The first comment by van Netten et al. is regarding the rationale for using a surrogate clinical outcome (ulcer area reduction) rather than ulcer healing by a fixed time, preferably 12 weeks, which would allow for direct comparisons with other articles on off-loading. It is important to note, as was outlined in our article, that the study associated with our publication was not limited …
- Open Access
- 6 June 2016
- Published by American Diabetes Association in Diabetes Care
- Vol. 39 (8) , 1371-1377
Role and Determinants of Adherence to Off-loading in Diabetic Foot Ulcer Healing: A Prospective Investigation
OBJECTIVE: Studies indicate that off-loading adherence is low in patients with diabetic foot ulcers (DFUs), which may subsequently delay healing. However, there is little empirical evidence for this relationship or the factors that influence adherence. RESEARCH DESIGN AND METHODS: This prospective, multicenter, international study of 79 (46 from the U.K. and 33 the U.S.) persons with type 2 diabetes and plantar DFUs assessed the association between off-loading adherence and DFU healing over a 6-week period. Additionally, potential demographic, disease, and psychological determinants of adherence were examined. DFUs were off-loaded with a removable device (77% a removable cast walker). Off-loading adherence was assessed objectively by activity monitors. Patient-reported measures included Hospital Anxiety and Depression Scale (HADS), Neuropathy and Foot Ulcer Quality of Life (NeuroQoL) instrument, and Revised Illness Perception Questionnaire (IPQ-R). RESULTS: Off-loading adherence was monitored for 35 ± 10 days, and devices were used during 59 ± 22% of subjects' activity. In multivariate analyses, smaller baseline DFU size, U.K. study site, and better off-loading adherence predicted smaller DFU size at 6 weeks (P < 0.05). Better off-loading adherence was, in turn, predicted by larger and more severe baseline DFUs, more severe neuropathy, and NeuroQoL foot pain (P < 0.05). In contrast, greater NeuroQoL postural instability predicted worse off-loading adherence (P < 0.001). HADS and IPQ-R measures were not significantly associated with off-loading adherence. CONCLUSIONS: Off-loading adherence is associated with the amount of DFU healing that occurs, while postural instability is a powerful predictor of nonadherence. Clinicians should take this neuropathic symptom into consideration when selecting an off-loading device, as off-loading–induced postural instability may further contribute to nonadherence.
- 6 June 2016
- Published by American Diabetes Association in Diabetes Care
- Vol. 39 (8) , 1371-1377
Open AccessRole and Determinants of Adherence to Off-loading in Diabetic Foot Ulcer Healing: A Prospective Investigation
OBJECTIVE: Studies indicate that off-loading adherence is low in patients with diabetic foot ulcers (DFUs), which may subsequently delay healing. However, there is little empirical evidence for this relationship or the factors that influence adherence. RESEARCH DESIGN AND METHODS: This prospective, multicenter, international study of 79 (46 from the U.K. and 33 the U.S.) persons with type 2 diabetes and plantar DFUs assessed the association between off-loading adherence and DFU healing over a 6-week period. Additionally, potential demographic, disease, and psychological determinants of adherence were examined. DFUs were off-loaded with a removable device (77% a removable cast walker). Off-loading adherence was assessed objectively by activity monitors. Patient-reported measures included Hospital Anxiety and Depression Scale (HADS), Neuropathy and Foot Ulcer Quality of Life (NeuroQoL) instrument, and Revised Illness Perception Questionnaire (IPQ-R). RESULTS: Off-loading adherence was monitored for 35 ± 10 days, and devices were used during 59 ± 22% of subjects' activity. In multivariate analyses, smaller baseline DFU size, U.K. study site, and better off-loading adherence predicted smaller DFU size at 6 weeks (P < 0.05). Better off-loading adherence was, in turn, predicted by larger and more severe baseline DFUs, more severe neuropathy, and NeuroQoL foot pain (P < 0.05). In contrast, greater NeuroQoL postural instability predicted worse off-loading adherence (P < 0.001). HADS and IPQ-R measures were not significantly associated with off-loading adherence. CONCLUSIONS: Off-loading adherence is associated with the amount of DFU healing that occurs, while postural instability is a powerful predictor of nonadherence. Clinicians should take this neuropathic symptom into consideration when selecting an off-loading device, as off-loading–induced postural instability may further contribute to nonadherence.
- 1 April 2016
- Published by Elsevier in Laboratory Investigation
- Vol. 96 (4) , 439-449
Oestrogen promotes healing in a bacterial LPS model of delayed cutaneous wound repair
- 1 April 2016
- Published by Elsevier in Laboratory Investigation
- Vol. 96 (4) , 439-449
Oestrogen promotes healing in a bacterial LPS model of delayed cutaneous wound repair
- 1 September 2014
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 134 (9) , 2447-2457
Estrogen Receptor-Alpha Promotes Alternative Macrophage Activation during Cutaneous Repair
- 1 September 2014
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 134 (9) , 2447-2457
Estrogen Receptor-Alpha Promotes Alternative Macrophage Activation during Cutaneous Repair